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QUESTIONS
1. What are the differences between CA-MRSA and HA-MRSA?
2. How does the study sample influence the study results?
3. How are S. aureus infections categorized?
4. What are the major findings of this study?
5. What may be the clinical implications of this article?
6. What further studies could be performed?
Methicillin-resistant Staphylococcus aureus (MRSA), first described in hospital settings 
(hospital-acquired or health care–associated MRSA; HA-MRSA), has garnered a tremendous 
amount of interest from both health-care workers and the general public since its discovery 
in 1961 (Barber, 1961). This interest stems from a number of factors, including the magnitude 
of the infections, the broader concern of antibiotic resistance, and media sensationalism 
of selected cases. Genetic resistance patterns as well as the initial locations of infection 
have recently shifted, with a trend toward affecting the nonhospitalized population. 
Community-associated MRSA (CA-MRSA) (Saravolatz et al., 1982) is even more intriguing 
to lay and professional groups. CA-MRSA is distinguished from HA-MRSA by its more 
limited antibiotic-resistance profile, differences in the toxins it produces, the population 
susceptible to it, and its propensity for outbreaks (Naimi et al., 2003). Of interest to dermatologists, CA-MRSA has a 
stronger predilection for skin involvement compared with HA-MRSA.
The emergence of MRSA in the community has led many physicians to wonder how prevalent these infections 
are and how they should be treated in the outpatient setting. These questions have been at least partly answered by 
the EMERGEncy ID Net Study Group, which reported that 59% of adult patients with acute purulent skin and soft-
tissue infections who presented to their emergency rooms were infected with MRSA (Moran et al., 2006). This study 
also demonstrated that the most effective treatment in this population was incision and drainage of the infection. 
Such studies provide tremendous insight into MRSA, yet they have also raised critical questions for practitioners in 
dermatology. In this issue, Jappe et al. analyze the frequency, antibiotic resistance, and molecular profiles of cutaneous 
infections from S. aureus in the outpatient dermatology clinic at the University of Heidelberg in Germany.
Over a 6-year period, the authors isolated S. aureus in 52% of their infected study population; 14% of these isolates 
were MRSA. Thus, only 7% of their total study population had MRSA. Additionally, via strict definitions as well as 
extensive genotyping and resistance profiling, Jappe et al. (2008) concluded that 22% of the total MRSA isolates were 
caused by CA-MRSA and the remainder due to HA-MRSA. These observations are intriguing because, contrary to many 
clinicians’ prior impressions, MRSA infections were relatively uncommon in this study population, with CA-MRSA 
accounting for only 1.4% of the total isolates.
Through the following questions, we examine this paper in greater detail. For brief answers, please refer to 
http://network.nature.com/group/jidclub.
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